AzTrials
AzTrials

Brain DeadNCT01070563

Transcranial Doppler Ultrasonography and Brain Death

An observational study of Brain Dead, run by Institut d'Anesthesiologie des Alpes Maritimes at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In France the diagnosis of brain death relies on electroencephalography (EEG) or cerebral angiography. Concerning the latter a time of 6 hours is mandatory between the clinical diagnosis and the realization of the cerebral computed tomography (CT) angiography. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Brain Dead
What is being tested?
Transcranial doppler
How many people
44 participants
Where
1 siteFrance
Study dates
Feb 2009to Jun 2011
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: ICU patients showing brain injury due to stroke or trauma and developping subsequently brain death

Who may be able to join

  • brain death patients

Who cannot join

  • craniectomy
  • post anoxia encephalopathy
  • no TCD performed before the clinical diagnosis of brain death
  • transtemporal approach impossible

Trial locations and contacts

1 site in 1 country.

France1 site
  • Centre Hospitalier Universitaire de Nice

    Nice, 06000

Other trials in France

About this study

Official title: Evaluation of Transcranial Doppler Ultrasonography to Guide the Time of Cerebral Angiography for the Brain Death Diagnosis

In France the diagnosis of brain death relies on electroencephalography (EEG) or cerebral angiography. Concerning the latter a time of 6 hours is mandatory between the clinical diagnosis and the realization of the cerebral computed tomography (CT) angiography. Transcranial doppler (TCD) is not recommended in the french guidelines for the diagnosis of brain death. In other countries, some flow patterns allow to confirm the diagnosis of brain death. The hypothesis of our study is that TCD could shorten the time between the clinical diagnosis of brain death and the realization of the CT angiography.

Conditions
Brain Dead
Being tested
Transcranial doppler
Keywords
Brain death, CT angiography, Ultrasonography, doppler, transcranial
Medical subject headings
Brain Death

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transcranial dopplerOther

    A TCD is performed on all cerebral arteries (mean cerebral arteries, anterior cerebral arteries, basilar trunk, vertebral arteries and carotid arteries) until a flow pattern compatible with brain death is found

Study groups in NCT01070563
Study groupRoleWhat they receive
UsualCT angiography is performed 6 hours after the clinical diagnosis of brain death.
TCDWhen the diagnosis of brain death is made, TCD is performed and then every 2 hours until the flow patterns compatible with brain death are found. Then a CT angiography is performed.
Receives: Other: Transcranial doppler

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time between clinical diagnosis of brain death and realization of CT angiography

    Measured: the outcome is assessed when the CT angiography is performed

Secondary outcomes (1)
  1. Number of CT angiography required for the diagnosis of brain death

    Measured: the outcome is measured until the diagnosis of brain death is confirmed

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Feb 2010 (estimated)
  2. Study startFeb 2009
  3. Primary completionJun 2011
  4. Study completionJun 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
44 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01070563
Sponsor's protocol ID
IAAM 2010-1
Status last verified
Jun 2011
First submitted
12 Feb 2010
Last updated
4 Jul 2011
Results posted
No
Data monitoring committee
No

Publications

  • Orban JC, El-Mahjoub A, Rami L, Jambou P, Ichai C. Transcranial Doppler shortens the time between clinical brain death and angiographic confirmation: a randomized trial. Transplantation. 2012 Sep 27;94(6):585-8. doi: 10.1097/TP.0b013e3182612947.

    PubMed 22918218

Questions about this trial

What is this clinical trial studying?

An observational study of Brain Dead, run by Institut d'Anesthesiologie des Alpes Maritimes at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Jul 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time between clinical diagnosis of brain death and realization of CT angiography (time frame: the outcome is assessed when the CT angiography is performed). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01070563, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jul 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in